Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structural features make it valuable in the design of serotonin and dopamine modulators, which are relevant for treating neurological and psychiatric disorders such as depression, anxiety, and schizophrenia. The presence of fluorine and trifluoromethoxy groups enhances blood-brain barrier penetration and metabolic stability, improving drug efficacy. Also employed in medicinal chemistry research for structure-activity relationship (SAR) studies to optimize receptor binding affinity and selectivity.